These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23824562)

  • 41. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody.
    Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design.
    Bedu-Addo F; Moreadith R; Advant SJ
    AAPS PharmSci; 2002; 4(4):E19. PubMed ID: 12645991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring Chemical Space for New Substances to Stabilize a Therapeutic Monoclonal Antibody.
    Tosstorff A; Menzen T; Winter G
    J Pharm Sci; 2020 Jan; 109(1):301-307. PubMed ID: 31697947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: role of conformational and colloidal stability.
    Goldberg DS; Bishop SM; Shah AU; Sathish HA
    J Pharm Sci; 2011 Apr; 100(4):1306-15. PubMed ID: 20960568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2020 Dec; 533(3):580-585. PubMed ID: 32988582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of the binding constants for three HPr-specific monoclonal antibodies and their Fab fragments.
    Smallshaw JE; Brokx S; Lee JS; Waygood EB
    J Mol Biol; 1998 Jul; 280(5):765-74. PubMed ID: 9671548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High throughput thermostability screening of monoclonal antibody formulations.
    He F; Hogan S; Latypov RF; Narhi LO; Razinkov VI
    J Pharm Sci; 2010 Apr; 99(4):1707-20. PubMed ID: 19780136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.
    Manikwar P; Majumdar R; Hickey JM; Thakkar SV; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2013 Jul; 102(7):2136-51. PubMed ID: 23620222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells.
    Zhao Y; Gutshall L; Jiang H; Baker A; Beil E; Obmolova G; Carton J; Taudte S; Amegadzie B
    Protein Expr Purif; 2009 Oct; 67(2):182-9. PubMed ID: 19442740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
    Sahin E; Grillo AO; Perkins MD; Roberts CJ
    J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of a high-throughput relative chemical stability assay to screen therapeutic protein formulations by assessment of conformational stability and correlation to aggregation propensity.
    Rizzo JM; Shi S; Li Y; Semple A; Esposito JJ; Yu S; Richardson D; Antochshuk V; Shameem M
    J Pharm Sci; 2015 May; 104(5):1632-40. PubMed ID: 25757872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
    Baek Y; Singh N; Arunkumar A; Zydney AL
    Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody.
    Liu H; Bulseco GG; Sun J
    Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rational Design of Biobetters with Enhanced Stability.
    Courtois F; Schneider CP; Agrawal NJ; Trout BL
    J Pharm Sci; 2015 Aug; 104(8):2433-40. PubMed ID: 26096711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biophysical characterization and structure of the Fab fragment from the NIST reference antibody, RM 8671.
    Karageorgos I; Gallagher ES; Galvin C; Gallagher DT; Hudgens JW
    Biologicals; 2017 Nov; 50():27-34. PubMed ID: 28965821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Orthogonal Methods for Characterizing the Unfolding of Therapeutic Monoclonal Antibodies: Differential Scanning Calorimetry, Isothermal Chemical Denaturation, and Intrinsic Fluorescence with Concomitant Static Light Scattering.
    Temel DB; Landsman P; Brader ML
    Methods Enzymol; 2016; 567():359-89. PubMed ID: 26794361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody.
    Roberts CJ; Nesta DP; Kim N
    J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.